← Every company
Ocugen Inc SEC Filings
What Ocugen Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
OCGN overview →Filings on file
193
since Sep 29, 2016
Warning signs
21
latest Jul 1, 2025
Last results
Aug 6, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
Source: Ocugen Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on OCGN
Company overviewEverything on OCGN in one place, with the price.Insider tradingWhat OCGN's own officers and directors buy and sell.Planned salesSales OCGN insiders have filed notice of.Executive payWhat OCGN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in OCGN.Funds holding itWhich funds and ETFs hold OCGN, and how big a bet.LobbyingWhat OCGN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on OCGN's account, and who they worked for.PatentsWhat OCGN is filing at the patent office.